What is Inhibrx Biosciences, Inc.'s net investment in lease?

Inhibrx Biosciences, Inc. (INBX) reported net investment in lease of $5.05M in Q1 2026.

How has Inhibrx Biosciences, Inc.'s net investment in lease changed year-over-year?

Inhibrx Biosciences, Inc.'s net investment in lease decreased by 26.8% year-over-year, from $6.9M to $5.05M.

What is the long-term trend for Inhibrx Biosciences, Inc.'s net investment in lease?

Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s net investment in lease has grown at a 36.9% compound annual growth rate (CAGR), from $2.95M to $5.54M.

Inhibrx Biosciences, Inc. INBX Net Investment in Lease

Net Investment in Lease at other companies

Rogers CorporationROG

——

Nuvation BioNUVB

——

ArriVent BioPharma, Inc.AVBP

——

ImmunomeIMNM

——

Replimune GroupREPL

——

IDEAYA Biosciences, Inc.IDYA

——

Other financials

Income statement

See full

Revenue--100%

Operating income-$30.9M+27.9%

Net income-$33.4M+22.8%

EPS (diluted)-$2.15+23.2%

Balance sheet

See full

Cash & equivalents$161.7M-25.3%

Total debt$180.9M+69.8%

Total equity-$21.0M-122%

Total assets$184.0M-24.2%

Cash flow

See full

Operating cash flow-$38.0M-5.9%

CapEx--100%

Free cash flow-$38.0M-5.9%

Valuation

See full

Market cap$1.4B+385%

Enterprise value$1.42B+982%

P/S1,073.7×-280×

Profitability

See full

Operating margin-10,386.5%-5,025pp

Net margin-10,773.5%-878,492pp

FCF margin-9,986.5%-4,727pp

Returns & leverage

See full

Return on equity-197.8%-2,158pp

Debt / equity13.4×+13.3×

Current ratio6.5×+1.3×

Where this comes from

Reported directly by Inhibrx Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inhibrx Biosciences, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Inhibrx Biosciences, Inc.'s net investment in lease?: Inhibrx Biosciences, Inc. (INBX) reported net investment in lease of $5.05M in Q1 2026.
How has Inhibrx Biosciences, Inc.'s net investment in lease changed year-over-year?: Inhibrx Biosciences, Inc.'s net investment in lease decreased by 26.8% year-over-year, from $6.9M to $5.05M.
What is the long-term trend for Inhibrx Biosciences, Inc.'s net investment in lease?: Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s net investment in lease has grown at a 36.9% compound annual growth rate (CAGR), from $2.95M to $5.54M.